|
C16ORF75 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.764000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.106800E-01 |
| Normal-vs-Stage2 |
5.311600E-01 |
| Normal-vs-Stage3 |
7.855600E-01 |
| Normal-vs-Stage4 |
9.045500E-02 |
| Stage1-vs-Stage2 |
3.325200E-01 |
| Stage1-vs-Stage3 |
5.041000E-01 |
| Stage1-vs-Stage4 |
8.115600E-02 |
| Stage2-vs-Stage3 |
6.754200E-01 |
| Stage2-vs-Stage4 |
2.965500E-02 |
| Stage3-vs-Stage4 |
4.596500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.308400E-01 |
| Normal-vs-AfricanAmerican |
2.124600E-01 |
| Normal-vs-Asian |
2.325800E-01 |
| Caucasian-vs-AfricanAmerican |
2.079800E-01 |
| Caucasian-vs-Asian |
1.192570E-01 |
| AfricanAmerican-vs-Asian |
4.238200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.949400E-01 |
| Normal-vs-Female |
8.940000E-01 |
| Male-vs-Female |
5.221600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.207960E-01 |
| Normal-vs-Age(41-60Yrs) |
3.722600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.460800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.041000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.832640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.297600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.962100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.929800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.442240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.308600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.651800E-01 |
| Normal-vs-Grade 2 |
8.399000E-01 |
| Normal-vs-Grade 3 |
6.857200E-01 |
| Normal-vs-Grade 4 |
1.889560E-01 |
| Grade 1-vs-Grade 2 |
5.586200E-01 |
| Grade 1-vs-Grade 3 |
8.288600E-01 |
| Grade 1-vs-Grade 4 |
7.300400E-01 |
| Grade 2-vs-Grade 3 |
3.860000E-01 |
| Grade 2-vs-Grade 4 |
1.037390E-01 |
| Grade 3-vs-Grade 4 |
2.610800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.126600E-01 |
| Normal-vs-ccB subtype |
1.544980E-01 |
| ccA subtype-vs-ccB subtype |
1.021400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.046600E-01 |
| Normal-vs-N1 |
6.029900E-02 |
| N0-vs-N1 |
6.147700E-02 |
|
|
